missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Mouse VEGFR3 ELISA Kit
Mouse VEGFR3 quantitates mouse VEGFR3 in serum, plasma, supernatant.
£504.00 - £2320.00
Specifications
| Accession Number | AI323512; Chy; chylous ascites; FLT4; FLT-4; FLT41; fms related tyrosine kinase 4; FMS-like tyrosine kinase 4; fms-related tyrosine kinase 4; LMPH1A; PCL; receptor protein tyrosine kinase; soluble VEGFR 3; sVEGFR 3; tyrosine-protein kinase receptor FLT4; Vascular endothelial growth factor receptor 3; vascular endothelial growth factor receptor-3; VEGF R3; Vegfr3; VEGFR-3 |
|---|---|
| Assay Range | 0.2 to 50 ng/mL |
| Assay Sensitivity | 0.2 ng/mL |
| Conjugate | Biotin |
| Product Type | ELISA |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
17115679
|
Invitrogen™
EM73RBX5 |
5 x 96 Tests |
£2320.00
Each |
Estimated Shipment: 24-05-2024
Log in to see stock. |
|||||
|
17194923
|
Invitrogen™
EM73RB |
96 Tests |
£504.00
Pack of 96 |
Estimated Shipment: 28-05-2024
Log in to see stock. |
|||||
Description
Mouse VEGFR3 quantitates mouse VEGFR3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse VEGFR3.
Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3. In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.Specifications
| AI323512; Chy; chylous ascites; FLT4; FLT-4; FLT41; fms related tyrosine kinase 4; FMS-like tyrosine kinase 4; fms-related tyrosine kinase 4; LMPH1A; PCL; receptor protein tyrosine kinase; soluble VEGFR 3; sVEGFR 3; tyrosine-protein kinase receptor FLT4; Vascular endothelial growth factor receptor 3; vascular endothelial growth factor receptor-3; VEGF R3; Vegfr3; VEGFR-3 | |
| 0.2 ng/mL | |
| ELISA | |
| P35917 | |
| <12% | |
| Pre-coated 96 well plate, Standard, Assay Diluent concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers | |
| Research Use Only | |
| VEGF Receptor 3 | |
| 4 hr 45 min |
| 0.2 to 50 ng/mL | |
| Biotin | |
| Colorimetric Microplate Reader | |
| FLT4 | |
| <10% | |
| HRP | |
| 2°C to 8°C | |
| 1 hr 20 min |